New dialyzer aims to cut down on dialysis symptoms
NCT ID NCT06032208
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is testing whether a new type of dialyzer, called Theranova, can help reduce common symptoms like pain, fatigue, and poor sleep in people with end-stage renal disease who are on dialysis. About 100 participants will use their usual dialyzer for the first 4 weeks and then switch to the Theranova dialyzer for 24 weeks, reporting their symptoms through a simple app. The goal is to see if removing larger toxins from the blood improves how patients feel.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Theranova dialyzer (a device used during hemodialysis to remove larger toxins)
What this could lead to
If it works, this could lead to better symptom management and improved quality of life for people on dialysis.
What could go wrong
This is a small, early-stage extension study with no control group, so results may not be conclusive. The new dialyzer may not significantly improve symptoms compared to standard care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for END STAGE RENAL DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
QEII Health Sciences Centre, Nova Scotia Health
RECRUITINGHalifax, Nova Scotia, B3H 1V7, Canada
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Seven Oaks Hospital Chronic Disease Innovation Centre Inc. (CDIC)
RECRUITINGWinnipeg, Manitoba, R2V 3M3, Canada
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Victoria Hospital, London Health Sciences Centre
RECRUITINGLondon, Ontario, N6A 5W9, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Westmount Kidney Care Centre
RECRUITINGLondon, Ontario, N6K 1M6, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••